Author's Reply to Şener and Begijanashvili: "Thromboembolism in Patients with Metastatic Renal Cell Carcinoma Treated with Immunotherapy"

Target Oncol. 2022 Jul;17(4):495-496. doi: 10.1007/s11523-022-00895-w. Epub 2022 Jul 11.

Authors

Iris Y Sheng¹, Alok A Khorana²

Affiliations

¹ Department of Medicine, Beth Israel Lahey Mount Auburn Hospital, Boston, MA, USA.
² Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, 10201 Carnegie Ave/CA 60, Cleveland, OH, 44106, USA. khorana@ccf.org.

PMID: 35819564
DOI: 10.1007/s11523-022-00895-w

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Renal Cell* / secondary
Humans
Immunotherapy
Kidney Neoplasms* / drug therapy
Thromboembolism*